S
KYNB

SignatureFD’s Kyntra Bio KYNB Stock Holding History

SignatureFD’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8
Closed -$3.84K – 3280
2023
Q1 		$3.84K Buy
8
+4
+100% +$2.12K ﹤0.01% 2604
2022
Q4 		$1.52K Buy
4
+1
+33% +$383 ﹤0.01% 2881
2022
Q3 		$1K Buy
+3
New +$966 ﹤0.01% 2954
2022
Q2 		– Sell
-4
Closed -$1K – 3178
2022
Q1 		$1K Buy
+4
New +$1.39K ﹤0.01% 2981

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD's KYNB Position: Q2 2023 in Review

SignatureFD sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 8 shares — an estimated $3.84K sold.

SignatureFD first reported a position in KYNB in Q1 2022 and held it in 4 quarters. The position peaked at $3.84K in Q1 2023. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • SignatureFD reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • SignatureFD sold 8 Kyntra Bio shares in Q2 2023, an estimated $3.84K.
  • SignatureFD first reported a position in Kyntra Bio in Q1 2022 and held it in 4 quarters.
  • SignatureFD's Kyntra Bio position peaked at $3.84K in Q1 2023.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.